"Immunoglobulin G" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
| Descriptor ID |
D007074
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393 D12.776.124.790.651.114.619.393 D12.776.377.715.548.114.619.393
|
| Concept/Terms |
IgG(T)- IgG(T)
- Immunoglobulin GT
- GT, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin G".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin G".
This graph shows the total number of publications written about "Immunoglobulin G" by people in this website by year, and whether "Immunoglobulin G" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 8 | 11 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 5 | 6 |
| 1999 | 6 | 9 | 15 |
| 2000 | 3 | 10 | 13 |
| 2001 | 3 | 8 | 11 |
| 2002 | 5 | 8 | 13 |
| 2003 | 2 | 9 | 11 |
| 2004 | 5 | 9 | 14 |
| 2005 | 4 | 10 | 14 |
| 2006 | 5 | 5 | 10 |
| 2007 | 9 | 7 | 16 |
| 2008 | 5 | 14 | 19 |
| 2009 | 2 | 9 | 11 |
| 2010 | 3 | 7 | 10 |
| 2011 | 3 | 9 | 12 |
| 2012 | 6 | 14 | 20 |
| 2013 | 5 | 12 | 17 |
| 2014 | 8 | 17 | 25 |
| 2015 | 7 | 16 | 23 |
| 2016 | 5 | 8 | 13 |
| 2017 | 2 | 15 | 17 |
| 2018 | 3 | 11 | 14 |
| 2019 | 2 | 15 | 17 |
| 2020 | 4 | 13 | 17 |
| 2021 | 3 | 12 | 15 |
| 2022 | 3 | 25 | 28 |
| 2023 | 1 | 19 | 20 |
| 2024 | 3 | 8 | 11 |
| 2025 | 3 | 11 | 14 |
| 2026 | 1 | 8 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulin G" by people in Profiles.
-
Evaluation of Serum Antibodies as Correlates of Protection Against Norovirus Infection and Disease. J Infect Dis. 2026 Sep 02; 234(2):220-228.
-
Heritable transgenic schistosomes as a living platform for SARS-CoV-2 neutralizing antibody secretion. Nat Commun. 2026 08 26; 17(1).
-
A clinical accuracy study protocol for a saliva-based point-of-care lateral flow test to assess protective immunity to tetanus (TETANUS study). BMJ Open. 2026 Aug 12; 16(8):e119202.
-
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. JAMA Neurol. 2026 May 01; 83(5):461-470.
-
Whose Line Is it Anyway? Defining Seropositivity Cutoffs for Infectious Disease Surveillance. J Infect Dis. 2026 Apr 29; 233(4):e862-e871.
-
A metabolic alarmin from keratinocytes potentiates systemic humoral immunity. Nature. 2026 04; 652(8108):209-219.
-
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost. Sci Transl Med. 2026 Feb 25; 18(838):eaeb9837.
-
Immunotherapy of TSA-1.C4 or in combination with BNZ confers protection against Trypanosoma cruzi infection with a distinct cytokine response. Vaccine. 2026 Mar 19; 76:128296.
-
Orally Acquired Chagas Disease in Rats Exposed to Naturally Infected Triatominae Bugs. Med J (Ft Sam Houst Tex). 2026; 108(2):24-34.
-
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial. Infection. 2026 Feb; 54(1):473-485.